Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 241-252 of 1376 results.
"This study underscores the high prevalence of CRBSIs and the concerning presence of molecular resistance markers in key pathogens. The predominance of carbapenemase genes such as blaNDM, blaKPC, and OXA variants highlights the urgent need for molecular diagnostics and robust antibiotic stewardship in India" Reddy et al (2025).
"A multimodal intervention significantly reduced CLABSI rates in the PICU, demonstrating the importance of comprehensive strategies in infection prevention. However, sustained compliance is essential to maintain these improvements" Subroongruang et al (2025).
"PN is associated with an increased risk of CLABSI in ward patients but not in ICU patients, suggesting context-dependent risk. Further work is needed to determine effective strategies for reducing rates of CLABSI among patients receiving PN hospital-wide and to validate these findings in broader patient populations" Gorsch et al (2025).
"These findings highlight the distal cephalic vein of the forearm as a practical and preferred initial site for peripherally compatible infusions when guided by structured ultrasound assessment, particularly in patients without renal impairment" Ostroff et al (2025).
"We found no significant association between the administration of irritants through midline catheters and catheter-related complications. However, the drug indications for midline catheters need to be further confirmed by well-conducted randomized clinical trials with large cohorts of patients" Zhang et al (2025).
"ICU nurses demonstrated generally inadequate knowledge of CLABSI prevention strategies, with less than one-third (28.2%) showing a high level of knowledge" Kahindi et al (2025).
"Pathway visualization improves PIVC placement accuracy, success rates, and alignment compared to point localization. The findings highlight its potential to improve cannulation in difficult intravenous access (DIVA) patients" Liddelow et al (2025).
"Our findings suggest the role of platelet activation in CADVT in critically ill children. Once confirmed, these biomarkers may be used to identify critically ill children who would benefit from pharmacologic prophylaxis" Regmi et al (2025).
"We sought to characterize thrombolytic agent use for restoration of CVC patency and assess its association with hospital-acquired venous thromboembolism (HA-VTE)" Sochet et al (2025).
"Ultrasound-guided innominate vein cannulation is safer and more effective than landmark-guided subclavian access in children, with higher success rates and fewer complications" Pablo Damián et al (2025).
"OPAT is typically administered in elastomeric devices, which release an infusion solution over a 24 h period and are meanwhile worn close to the body. This work aimed to evaluate the stability of the reserve antibiotics ceftazidime-avibactam and ceftolozane-tazobactam for OPAT use" Erdmann et al (2025).
"We aim to determine the accuracy of the anatomical landmark technique for finding the femoral vein vs. the ultrasound-guided technique. We hypothesize that the femoral vein location using anatomical landmarks is, on average, 10 mm or more away from the femoral vein location found using ultrasound" Sonka et al (2025).
